HOLX News and Press, Hologic Inc. From 07/22/21

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

gopixa/iStock via Getty Images Many of the coronavirus test makers and vaccine developers are trading higher in morning hours while the U.S. stocks have trended lower amid concerns over a spike in COVID-19 infections and deaths across the country after weeks of decline. Moderna ([[MRNA]] +6.5...

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA And Healthcare Dashboard For July

Hologic (HOLX) has obtained a CE Mark for the use of saliva samples with the Aptima SARS-CoV-2 assay in Europe.The Aptima SARS-CoV-2 test is a molecular diagnostic assay that detects the genetic material of the pathogen causing COVID-19. The test runs on the fully automated Panther system. Th...

Hologic, Inc. (Nasdaq: HOLX) has obtained a CE Mark for the use of saliva samples with the Aptima® SARS-CoV-2 assay in Europe. The Aptima SARS-CoV-2 test is a molecular diagnostic assay that detects the genetic material of the pathogen causing COVID-19. The test runs on the fully a...

Its rapid tech integration and huge spending on research and development position the healthcare industry well to generate sustainable growth over the long term. So, we think it could be wise to bet now on cheap healthcare stocks Hologic, Inc. (HOLX) and Owens & Minor, Inc. (OMI). They po...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

The global economic recovery can be attributed in large measure to the efforts of several healthcare companies in their race to develop a COVID-19 vaccine. With governments now pouring billions of dollars to further improve the healthcare industry, and companies in the sector focusing on meet...

Viktoriia Hnatiuk/iStock via Getty Images Hologic upgraded on tuck-in M&A strategy Evercore ISI is upgrading shares of Hologic ([[HOLX]] -0.4%) to outperform with a $78 price target (~15% upside). The firm says that the women's health and diagnostics player is poised for future tuck-in ac...

Hologic upgraded on tuck-in M&A strategyEvercore ISI is upgrading share of Hologic ([[HOLX]] -0.4%) to outperform with a $78 price target (~15% upside).The firm says that the women's health and diagnostics player is poised for future tuck-in acquisitions, funded with profits from its COVI...